LONDON, July 25, 2017 /PRNewswire/ -- The European next-generation sequencing (NGS) informatics market is expanding,
"As the industry matures, users of NGS informatics services will seek seamless end-to-end genetic solutions in an easy-to-use format at competitive prices," said Transformational Health Senior Industry Analyst Neelotpal Goswami. "Intensifying demand from pharmaceuticals, biotech, and diagnostic firms will propel NGS informatics providers to develop customized solutions that address user needs—from sample analysis to actionable informatics. In addition to extensive use in diagnostics and the development of precision medicine, NGS informatics will find applications in areas such as agriculture, plant and animal biotechnology, consumer products, and food and nutrition."
Growth Opportunities in the European Next-generation Sequencing Informatics Market, Forecast to 2021, part of Frost & Sullivan's Life Sciences Growth Partnership Service program, examines the European NGS informatics services market, outlining market drivers, restraints and emerging trends. The study details unmet needs and highlights potential opportunities across the secondary analysis, tertiary analysis and storage solution segments.
To access more information on this analysis, please click here.
Frost & Sullivan expects the European NGS informatics market to be worth $508.6 million by 2021. Trends supporting market development include:
"Europe is a fragmented market, where revenue potential varies significantly in individual countries. Additionally, at a pan-European market level, countries have differing regulations and reimbursement practices that may hamper successful commercialization of NGS informatics solutions," observed Goswami. "However, innovative approaches, such as storing genomic data for analysis within specified geographic borders to match data storage regulations, and evolution in reimbursement policies that increase clarity and coverage for NGS-based tests, will support growth opportunities."
As service providers build comprehensive service capabilities, mergers, acquisitions, and collaborations are likely to increase across the NGS value chain. Companies to watch in this space include QIAGEN, Illumina, Congenica, Eagle Genomics, BC Platforms, Bluebee, Sophia Genetics, Genestack, and GENALICE.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community.
Growth Opportunities in the European Next-generation Sequencing Informatics Market, Forecast to 2021MD05-55
Contact:Mariana FernandezCorporate Communications P: +1 (210) 348 1012E: Mariana.Fernandez@frost.com
http://ww2.frost.comtwitter: @FS_Healthcare LinkedIn: Transform Health
Subscribe to our Free Newsletters!
Nootropics are drugs or substances which improve cognition that are being increasingly used ...